Europe Eyelid Surgery Blepharoplasty Market Growth Prospects 2024-2032
According to Triton’s analysis, the Europe eyelid surgery blepharoplasty market is projected to rise at a CAGR of 6.34% in revenue over the forecast years 2024-2032.
The European blepharoplasty market is experiencing robust growth driven by demographic and cultural factors. The region’s aging population, with nearly 21% aged 65 or older, has led to an increased demand for blepharoplasty surgery as individuals seek to address age-related issues such as sagging skin and drooping eyelids. Technological advancements in cosmetic surgery, particularly the adoption of minimally invasive techniques like laser-assisted procedures, are also contributing to market growth. These innovations ensure safer, more precise outcomes with shorter recovery times, making eyelid surgeries increasingly appealing. Additionally, rising disposable incomes across many European nations have made cosmetic procedures more accessible, thereby influencing the progress of the eyelid surgery blepharoplasty market.
The countries explored in this region include the United Kingdom, Germany, France, Spain, Italy, Poland, and Rest of Europe.
Germany secures a major market share with revenue of approximately $96.71 million in 2023.
- As per the IASPS survey in 2023, eyelid surgery is one of the most popular cosmetic procedures in Germany, representing about 4.1% of all surgical aesthetic procedures. The country’s advanced expertise in lasers and plasma technology drives the adoption of minimally invasive blepharoplasty techniques, offering improved results with faster recovery times.
- Additionally, the authorities have underlined rigorous professional standards to ensure high-quality procedures, with plastic surgeons undergoing extensive training and certification under strong government oversight.
- To make the eyelid surgeries affordable and accessible to everyone, value-priced options are now available that cater to the cost-conscious middle class, fueling blepharoplasty market growth.
Eyelid Surgery Blepharoplasty Market Forecast for the United Kingdom
According to the International Society of Aesthetic Plastic Surgery, approximately 15,186 eyelid surgeries were performed in the UK in 2023, reflecting robust demand in the market. Notably, over 90% of eyelid surgeries were performed on individuals aged 40 and above. While women have traditionally dominated demand for blepharoplasty surgery, men now account for over 30% of patients, signaling a growing acceptance of cosmetic procedures across genders and expanding the scope of upper eyelid surgery. These numbers show a promising market growth for blepharoplasty surgery in the coming years.
The rodent control market is segmented based on procedure type, gender, product type, and end-user. The procedure type segment comprises upper eyelid blepharoplasty, lower eyelid blepharoplasty, and combination eyelid surgery. Upper eyelid blepharoplasty primarily addresses aging-related drooping and hooding of the upper eyelids that can impair peripheral vision. By removing excess fat, muscle, and skin, the procedure offers both functional and cosmetic benefits. Its simplicity, quick recovery, and low risk make it appealing to a wide range of consumers.
Contender Analysis in the Eyelid Surgery Blepharoplasty Market:
Sciton Inc offers the JOULE™ laser and dissector system, designed to enhance drooping eyelids, resurface eyelid skin, and more. Their fully customizable platforms and specialized techniques enable precise laser treatments for the delicate tissue around the eyes, minimizing the risk of scarring or depigmentation. Over 8,000 eye specialists worldwide rely on their system. The company is headquartered in California, United States.
In April 2024, the company launched the BBL HEROic, a groundbreaking advancement in pulsed light technology. The system tracks the treatment handpiece in six degrees of freedom, enabling multi-dimensional positioning for precise pulse placement on both flat and contoured body areas.
Other contenders in the studied market are Cynosure Inc, Bomtech Electronics Co Ltd, IOPtima, Grand Aespio Inc, and LightScalpel.